Kenya explores ways of strengthening research commercialisation for knowledge growth, job creation
Head of Public Service noted that there are encouraging signs in the endeavour, as the research-to-commercialisation programme (R2C) being spearheaded by the Kenya National Innovation Agency (KeNIA) in partnership with ViKtoria Ventures has shown that research can become viable.
Fast quest for coronavirus vaccines and what it means for other diseases
When scientists began seeking a vaccine for the SARS-CoV-2 coronavirus in early 2020, they were careful not to promise quick success. The fastest any vaccine had previously been developed, from viral sampling to approval, was four years, for mumps in the 1960s. To hope for one even by the summer...
